Picture of Biostem Technologies logo

BSEM Biostem Technologies Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Biostem Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2015
December 31st
R2016
December 31st
R2017
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:PRESSARSInterim ReportARSARS
Standards:
USG
USG
U
USG
U
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments0.4120.1760.0520.1010.34
Net Total Accounts Receivable
Net Total Receivables0.1520.0320.0190.0120.3
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.7850.3160.2310.8511
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment1.341.781.681.351.28
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets2.943.232.392.672.74
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities0.7922.261.16.86.73
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities1.292.251.578.478.3
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity1.640.9740.818-5.8-5.57
Total Liabilities & Shareholders' Equity2.943.232.392.672.74
Total Common Shares Outstanding
Total Preferred Shares Outstanding